Plasma free and sulfoconjugated dopamine before and after a half-marathon. 1995

T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
Department of Internal Medicine, School of Medicine, Fukuoka University, Japan.

To elucidate whether increased plasma levels of free dopamine (F-DA) after exercise are due to deconjugation of sulfoconjugated (S-) DA in plasma, we compared the changes in plasma F- and S- DA, as well as changes in both the S- and F- forms of epinephrine (E) and norepinephrine (NE), after running a half-marathon. Free catecholamines (F-CAs) were measured by automated high-performance liquid chromatography (HPLC). Total (F+S) CAs were determined using an efficient deconjugation method as follows; 1200 microliters plasma was incubated with 152 mU arylsulfatase (AS) for 30 min at pH 7.6. The plasma levels of F-CA (pg/ml) (mean +/- SEM) all increased significantly (p < 0.01) after the half-marathon; i.e., F-DA increased from 13.3 +/- 5.7 to 176.3 +/- 32.2; F-E from 58.0 +/- 12.3 to 764.3 +/- 136.4; F-NE from 246.6 +/- 15.2 to 3082.0 +/- 690.3. OF S-CAs, S-E (from 127.8 +/- 26.0 to 1218.2 +/- 190.8) and S-NE (from 717.1 +/- 61.6 to 5586.9 +/- 761.9) also increased, but, in contrast, among the S-CAs, only the increase in S-DA (from 5324.9 +/- 1967.3 to 7359.6 +/- 1627.9) was not statistically significant. Sulfoconjugation may play an important role in inactivating F-DA as well as F-NE and -E, that are released into plasma in response to vigorous exercise. Thus, plasma F-DA is unlikely to be derived through deconjugation of plasma S-DA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004837 Epinephrine The active sympathomimetic hormone from the ADRENAL MEDULLA. It stimulates both the alpha- and beta- adrenergic systems, causes systemic VASOCONSTRICTION and gastrointestinal relaxation, stimulates the HEART, and dilates BRONCHI and cerebral vessels. It is used in ASTHMA and CARDIAC FAILURE and to delay absorption of local ANESTHETICS. Adrenaline,4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-benzenediol,Adrenaline Acid Tartrate,Adrenaline Bitartrate,Adrenaline Hydrochloride,Epifrin,Epinephrine Acetate,Epinephrine Bitartrate,Epinephrine Hydrochloride,Epinephrine Hydrogen Tartrate,Epitrate,Lyophrin,Medihaler-Epi,Acetate, Epinephrine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001192 Arylsulfatases Enzymes that catalyze the hydrolysis of a phenol sulfate to yield a phenol and sulfate. Arylsulfatase A, B, and C have been separated. A deficiency of arylsulfatases is one of the causes of metachromatic leukodystrophy (LEUKODYSTROPHY, METACHROMATIC). EC 3.1.6.1. Arylsulfatase,Arylsulfate Sulfohydrolase,Arylsulfate Sulfohydrolases,Arylsulphatase,Arylsulphatases,Pseudo Arylsulfatase A,Sulfohydrolase, Arylsulfate
D013431 Sulfates Inorganic salts of sulfuric acid. Sulfate,Sulfates, Inorganic,Inorganic Sulfates

Related Publications

T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
January 1992, Life sciences,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
July 1989, Klinische Wochenschrift,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
June 1988, Danish medical bulletin,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
February 1990, Journal of applied physiology (Bethesda, Md. : 1985),
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
October 1982, European heart journal,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
June 1995, Hypertension research : official journal of the Japanese Society of Hypertension,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
January 1988, European journal of applied physiology and occupational physiology,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
March 2011, Sports health,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
June 1982, Archives des maladies du coeur et des vaisseaux,
T Sakai, and H Maeda, and N Matsumoto, and S Miura, and A Kinoshita, and M Sasaguri, and M Ideishi, and H Tanaka, and M Shindo, and K Arakawa
January 1989, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Copied contents to your clipboard!